0
Article |

Possible Association Between Breast Cancer and Malignant Melanoma

Tim Byers, MD, MPH; Harvey Arbesman, MD
[+] Author Affiliations

Departments of Dermatology and Social and Preventive Medicine; Department of Social and Preventive Medicine School of Medicine State University of New York at Buffalo 2211 Main St Buffalo, NY 14214


Arch Dermatol. 1988;124(7):1007-1007. doi:10.1001/archderm.1988.01670070009002
Text Size: A A A
Published online

To the Editor.—  A letter was recently published suggesting an association between breast cancer and malignant melanoma.1 Hormonal factors were suggested by the authors as possibly having a role in explaining this observation. Based on the following studies, depressed pineal gland secretion of melatonin might hypothetically contribute to the development of both malignancies.Cohen et al2 first suggested the role of the pineal gland in the pathogenesis of breast cancer in 1978. It has been shown in experimental animals that decreased levels of melatonin result in increased levels of estrogen and prolactin.3 Receptors to estrogen and other hormones have been found on both breast cancer and melanoma cells.4,5 Pinealectomy in experimental animals results in increased growth of both dimethylbenz(a)anthracene-induced mammary tumors and transplanted melanomas,6,7 and replacement melatonin reverses these adverse effects.6,8 In addition, patients with estrogen-receptor-positive breast cancer and patients with melanoma have decreased

REFERENCES

Koh HK, Sober AJ, Carey RA:  Possible association between malignant melanoma and breast cancer . Arch Dermatol 1987;;123:712-713.
Cohen M, Lippman M, Chabner B:  Role of pineal gland in aetiology and treatment of breast cancer . Lancet 1978;;2:814-816.
Mhate MC, Shah PN, Juneja MS:  Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats . JNCI 1984;;72:1411-1416.
Desombre ER, Greene GL, Jensen EV:  Estrophilin and endocrine responsiveness of breast cancer , in McGuire WL (ed): Hormones, Receptors, and Breast Cancer . New York, Raven Press, 1978;, pp 1-14.
Fisher RI, Niefield JP, Lippman ME:  Estrogen receptors in human malignant melanoma . Lancet 1976;;2:337-338.
Tamarkin L, Cohen M, Roselle D, et al:  Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat . Cancer Res 1981;; 41:4432-4436.
Das Gupta TK, Terz J:  Influence of pineal gland on the growth and spread of melanoma in the hamster . Cancer Res 1967;;27:1306-1311.
El-Domeiri AAH, Das Gupta TK:  Reversal by melatonin of the effect of pinealectomy on tumor growth . Cancer Res 1973;;33:2830-2833.
Tamarkin L, Danforth D, Lichter A, et al:  Decreased nocturnal plasma melatonin peak in patients with estrogen receptorpositive breast cancer . Science 1982;;216:1003-1005.
Grinevich YA, Labunetz IF:  Melatonin, thymic serum factor, and cortisol levels in healthy subjects of different age and patients with skin melanoma . J Pineal Res 1986;;3:263-275.
Moore DC, Paunier L, Sizonenko PC:  Effect of adrenergic stimulation and blockade on melatonin secretion in the human . Progr Brain Res 1979;;52:517-521.
Cowen PJ, Bevan JS, Gosden B, et al:  Treatment with β-adrenoceptor blockers reduces plasma melatonin concentration . Br J Clin Pharm 1985;;19:258-260.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Koh HK, Sober AJ, Carey RA:  Possible association between malignant melanoma and breast cancer . Arch Dermatol 1987;;123:712-713.
Cohen M, Lippman M, Chabner B:  Role of pineal gland in aetiology and treatment of breast cancer . Lancet 1978;;2:814-816.
Mhate MC, Shah PN, Juneja MS:  Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats . JNCI 1984;;72:1411-1416.
Desombre ER, Greene GL, Jensen EV:  Estrophilin and endocrine responsiveness of breast cancer , in McGuire WL (ed): Hormones, Receptors, and Breast Cancer . New York, Raven Press, 1978;, pp 1-14.
Fisher RI, Niefield JP, Lippman ME:  Estrogen receptors in human malignant melanoma . Lancet 1976;;2:337-338.
Tamarkin L, Cohen M, Roselle D, et al:  Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat . Cancer Res 1981;; 41:4432-4436.
Das Gupta TK, Terz J:  Influence of pineal gland on the growth and spread of melanoma in the hamster . Cancer Res 1967;;27:1306-1311.
El-Domeiri AAH, Das Gupta TK:  Reversal by melatonin of the effect of pinealectomy on tumor growth . Cancer Res 1973;;33:2830-2833.
Tamarkin L, Danforth D, Lichter A, et al:  Decreased nocturnal plasma melatonin peak in patients with estrogen receptorpositive breast cancer . Science 1982;;216:1003-1005.
Grinevich YA, Labunetz IF:  Melatonin, thymic serum factor, and cortisol levels in healthy subjects of different age and patients with skin melanoma . J Pineal Res 1986;;3:263-275.
Moore DC, Paunier L, Sizonenko PC:  Effect of adrenergic stimulation and blockade on melatonin secretion in the human . Progr Brain Res 1979;;52:517-521.
Cowen PJ, Bevan JS, Gosden B, et al:  Treatment with β-adrenoceptor blockers reduces plasma melatonin concentration . Br J Clin Pharm 1985;;19:258-260.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.